{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:48:32Z","timestamp":1790891312650,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jcyt.2017.08.012","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T22:00:17Z","timestamp":1505253617000},"page":"1256-1269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Granulocyte transfusions: A concise review for practitioners"],"prefix":"10.1016","volume":"19","author":[{"given":"Juan","family":"Gea-Banacloche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jcyt.2017.08.012_bib0010","article-title":"Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction","author":"Estcourt","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.012_bib0015","article-title":"Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction","author":"Estcourt","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00000441-193404000-00010","article-title":"The effect of leukocytic cream injections in the treatment of the neutropenias","volume":"187","author":"Strumia","year":"1934","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3181\/00379727-84-20539","article-title":"Transfusion of separated leukocytes into irradiated dogs with aplastic marrows","volume":"84","author":"Brecher","year":"1953","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0030","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1182\/blood.V34.6.782.782","article-title":"The effect of leukocyte transfusions on experimental bacteremia in the dog","volume":"34","author":"Epstein","year":"1969","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0035","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1749-6632.1964.tb40726.x","article-title":"The function and fate of transfused leukocytes from donors with chronic myeloid leukaemia in leukopenic recipients","volume":"113","author":"Freireich","year":"1964","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0040","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.tmrv.2011.04.004","article-title":"Leukocyte transfusion and the development of the continuous-flow blood cell separator","volume":"25","author":"Freireich","year":"2011","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0045","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1056\/NEJM197208242870801","article-title":"Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria","volume":"287","author":"Graw","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0050","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1056\/NEJM197504102921501","article-title":"Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies","volume":"292","author":"Higby","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0055","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM197703312961301","article-title":"Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study","volume":"296","author":"Herzig","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0060","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0002-9343(77)90200-5","article-title":"A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia","volume":"63","author":"Vogler","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0065","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.1537-2995.1975.15676082229.x","article-title":"Granylocyte transfusion: a controlled study in patients with acute nonlymphocytic leukemia","volume":"15","author":"Fortuny","year":"1975","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0070","doi-asserted-by":"crossref","first-page":"509","DOI":"10.7326\/0003-4819-97-4-509","article-title":"Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes","volume":"97","author":"Winston","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0075","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM198105143042001","article-title":"Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions","volume":"304","author":"Wright","year":"1981","journal-title":"N Engl J Med"},{"issue":"1993","key":"10.1016\/j.jcyt.2017.08.012_bib0080","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1182\/blood.V81.7.1675.1675","article-title":"Therapeutic granulocyte transfusions in","volume":"81","author":"Strauss","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0085","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1182\/blood.V81.7.1883.1883","article-title":"The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis","volume":"81","author":"Bensinger","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0090","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1537-2995.2001.41081037.x","article-title":"Administration of G\u2013CSF plus dexamethasone produces greater granulocyte concentrate yields while causing no more donor toxicity than G\u2013CSF alone","volume":"41","author":"Stroncek","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0095","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1423-0410.2010.01417.x","article-title":"Preparation of granulocyte concentrates by apheresis: collection modalities in the USA","volume":"100","author":"Strauss","year":"2011","journal-title":"Vox Sang"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0100","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1423-0410.2010.01315.x","article-title":"Preparation of granulocyte concentrates by apheresis","volume":"98","author":"Leitner","year":"2010","journal-title":"Vox Sang"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0105","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1182\/blood-2015-05-645986","article-title":"Efficacy of transfusion with granulocytes from G-CSF\/dexamethasone treated donors in neutropenic patients with infection","volume":"126","author":"Price","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0110","series-title":"Guide to the preparation, use and quality assurance of blood components : recommendation No. R (95) 15","author":"de Conseil","year":"2015"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0115","series-title":"Clinical guidelines for the use of granulocyte transfusions","author":"Massey","year":"2012"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0120","first-page":"9","article-title":"Function of granulocytes collected for transfusion","volume":"88","author":"Strauss","year":"1982","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1365-3148.2003.00451.x","article-title":"Granulocyte concentrates: how can we assess their quality?","volume":"13","author":"Bashir","year":"2003","journal-title":"Transfus Med"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0130","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2141.2008.06996.x","article-title":"Neutrophil function is preserved in a pooled granulocyte component prepared from whole blood donations","volume":"140","author":"Bashir","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0135","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12967-015-0724-5","article-title":"Granulocyte transfusions in children and adults with hematological malignancies: benefits and controversies","volume":"13","author":"Cugno","year":"2015","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0140","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3324\/haematol.2015.136630","article-title":"Impaired killing of Candida albicans by granulocytes mobilized for transfusion purposes: a role for granule components","volume":"101","author":"Gazendam","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0145","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/leu.2012.301","article-title":"A prospective, randomized, double-blind study, comparing unirradiated to irradiated white blood cell transfusions in acute leukemia patients","volume":"27","author":"Freireich","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0150","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1111\/trf.13099","article-title":"Role of granulocyte transfusions in invasive fusariosis: systematic review and single-center experience","volume":"55","author":"Kadri","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0155","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1046\/j.1537-2995.2002.00249.x","article-title":"Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors","volume":"42","author":"H\u00fcbel","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0160","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/bmt.2008.237","article-title":"Randomized phase III study of granulocyte transfusions in neutropenic patients","volume":"42","author":"Seidel","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0165","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/MPH.0b013e318196a6f9","article-title":"Granulocyte transfusions in children and young adults: does the dose matter?","volume":"31","author":"Seidel","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0170","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1182\/blood-2015-09-669085","article-title":"Granulocyte transfusion: questions remain","volume":"126","author":"Cancelas","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0175","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/MOH.0000000000000189","article-title":"Neutrophil\/granulocyte transfusions collected from G-CSF\u2009+\u2009dexamethasone-stimulated donors","volume":"22","author":"Strauss","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159569","article-title":"Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia","volume":"11","author":"Teofili","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0185","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/pbc.22926","article-title":"Antibiotic resistance is associated with longer bacteremic episodes and worse outcome in febrile neutropenic children with cancer","volume":"57","author":"El-Mahallawy","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0190","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3947\/ic.2016.48.3.181","article-title":"Increase in antibiotic-Resistant gram-negative bacterial infections in febrile neutropenic children","volume":"48","author":"Lee","year":"2016","journal-title":"Infect Chemother"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0195","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2017.02.026","article-title":"Granulocyte transfusions in patients with chronic granulomatous disease and refractory infections: the NIH experience","volume":"140","author":"Marciano","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0200","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1537-2995.2010.02993.x","article-title":"The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort","volume":"51","author":"Heim","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0205","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3324\/haematol.2009.010231","article-title":"Granulocyte transfusions in severe aplastic anemia: an eleven-year experience","volume":"94","author":"Quillen","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0210","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s10096-013-1924-7","article-title":"Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment","volume":"32","author":"Guarro","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0215","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3109\/14653249.2010.529889","article-title":"Therapeutic granulocyte transfusions for the treatment of febrile neutropenia in patients with hematologic diseases: a 10-year experience at a single institute","volume":"13","author":"Kim","year":"2011","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0220","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/cncr.20710","article-title":"Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections","volume":"101","author":"Safdar","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0225","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/annonc\/mdt110","article-title":"Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complications","volume":"24","author":"Raad","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0230","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000351174","article-title":"Use of healthy-donor granulocyte transfusions to treat infections in neutropenic patients with myeloid or lymphoid neoplasms: experience in 74 patients treated with 373 granulocyte transfusions","volume":"131","author":"Safdar","year":"2014","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0235","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-3148.2012.01152.x","article-title":"The granulocytes in neutropenia 1 (GIN 1) study: a safety study of granulocytes collected from whole blood and stored in additive solution and plasma","volume":"22","author":"Massey","year":"2012","journal-title":"Transfus Med"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0240","doi-asserted-by":"crossref","first-page":"e88148","DOI":"10.1371\/journal.pone.0088148","article-title":"Granulocyte transfusion combined with granulocyte colony stimulating factor in severe infection patients with severe aplastic anemia: a single center experience from China","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0245","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1056\/NEJM197703312961302","article-title":"A randomized clinical trial of granulocyte transfusions for infection in acute leukemia","volume":"296","author":"Alavi","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0250","first-page":"1583","article-title":"[Granulocyte substitution in febrile leukemia patients with bone marrow aplasia. 1. Results of a prospective study]","volume":"108","author":"Scali","year":"1978","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0255","first-page":"46","article-title":"Early granulocyte transfusions in high risk febrile neutropenic patients","volume":"14","author":"Klastersky","year":"1983","journal-title":"Schweiz Med Wochenschr Suppl"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0260","first-page":"593","article-title":"Pulmonary complications in patients receiving granulocyte transfusions and amphotericin B","volume":"130","author":"Bow","year":"1984","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0265","first-page":"21","article-title":"Controlled study of therapeutic granulocyte transfusions in granulocytopenic patients with severe infections","volume":"14","author":"Matsue","year":"1984","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-1101(1996)11:1<1::AID-JCA1>3.0.CO;2-F","article-title":"Meta-analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis","volume":"11","author":"Vamvakas","year":"1996","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0275","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM197805112981904","article-title":"Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplants","volume":"298","author":"Clift","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0280","first-page":"503","article-title":"Efficiency of prophylactic granulocyte transfusions in preventing infections in acute leukaemia","volume":"22","author":"Mannoni","year":"1979","journal-title":"Rev Fr Transfus Immunohematol"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0285","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0002-9343(80)90223-5","article-title":"Prophylactic granulocyte transfusions during human bone marrow transplantation","volume":"68","author":"Winston","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0290","doi-asserted-by":"crossref","first-page":"616","DOI":"10.7326\/0003-4819-94-5-616","article-title":"Prophylactic granulocyte transfusions during chemotherapy of acute nonlymphocytic leukemia","volume":"94","author":"Winston","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0295","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJM198109103051101","article-title":"A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia","volume":"305","author":"Strauss","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0300","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1537-2995.1982.22482251217.x","article-title":"Prophylactic granulocyte transfusions: results of a randomized controlled trial in patients with acute myelogenous leukemia","volume":"22","author":"Ford","year":"1982","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0305","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1182\/blood.V54.4.766.766","article-title":"Alloimmunization following prophylactic granulocyte transfusion","volume":"54","author":"Schiffer","year":"1979","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0310","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/1097-0142(1984)54:4<734::AID-CNCR2820540424>3.0.CO;2-W","article-title":"A controlled trial of prophylactic granulocyte transfusions during induction chemotherapy for acute nonlymphoblastic leukemia","volume":"54","author":"Gomez-Villagran","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0315","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1017\/S0195941700065437","article-title":"Prevention of nosocomial infections in marrow transplant patients: a prospective randomized comparison of systemic antibiotics versus granulocyte transfusions","volume":"7","author":"Petersen","year":"1986","journal-title":"Infect Control"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0320","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1040-8428(87)80016-1","article-title":"Granulocyte transfusions in neutropenic patients","volume":"7","author":"Menitove","year":"1987","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0325","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/(SICI)1098-1101(1997)12:2<74::AID-JCA4>3.0.CO;2-6","article-title":"Determinants of the efficacy of prophylactic granulocyte transfusions: a meta-analysis","volume":"12","author":"Vamvakas","year":"1997","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0330","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00277-002-0439-6","article-title":"Treatment and prophylaxis of severe infections in neutropenic patients by granulocyte transfusions","volume":"81","author":"Illerhaus","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0335","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood-2002-07-2110","article-title":"Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation","volume":"101","author":"Vij","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0340","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1537-2995.2005.00665.x","article-title":"Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage","volume":"46","author":"Oza","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0345","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s00277-005-1055-z","article-title":"Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia","volume":"84","author":"Mousset","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0350","first-page":"783","article-title":"Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G-CSF-mobilized granulocyte transfusions in three children with hematological malignancies","volume":"14","author":"Grigull","year":"2006","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0355","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/bmt.2015.53","article-title":"Single-donor granulocyte transfusions for improving the outcome of high-risk pediatric patients with known bacterial and fungal infections undergoing stem cell transplantation: a 10-year single-center experience","volume":"50","author":"Nikolajeva","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2017.08.012_bib9000","first-page":"4","article-title":"Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated Fusarium solani infection","volume":"8","author":"Sheela","year":"2017","journal-title":"Leuk Res Rep"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0360","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1046\/j.1537-2995.1977.17578014584.x","article-title":"Consequences of prior alloimmunization during granulocyte transfusion","volume":"17","author":"Appelbaum","year":"1977","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0365","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1537-2995.1979.19179160275.x","article-title":"Lack of predictive value of antileukocyte antibody screening in granulocyte transfusion therapy","volume":"19","author":"Ungerleider","year":"1979","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0370","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1046\/j.1537-2995.1996.36111297091747.x","article-title":"Alloimmunization after granulocyte transfusions","volume":"36","author":"Stroncek","year":"1996","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0375","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood-2011-10-345751","article-title":"Blood consult: granulocyte transfusions to treat invasive aspergillosis in a patient with severe aplastic anemia awaiting mismatched hematopoietic progenitor cell transplantation","volume":"119","author":"O'Donghaile","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0380","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jcyt.2017.08.012_bib0385","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.transci.2009.05.016","article-title":"Granulocyte transfusions for pediatric patients and the establishment of national treatment guidelines and donor registry","volume":"41","author":"Vrielink","year":"2009","journal-title":"Transfus Apher Sci"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324917306710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324917306710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:33:11Z","timestamp":1761442391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324917306710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":77,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1465324917306710"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2017.08.012","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Granulocyte transfusions: A concise review for practitioners","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2017.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of International Society for Cellular Therapy.","name":"copyright","label":"Copyright"}]}}